Skip to content
HowShorted

CHEMBIO DIAGNOSTICS, INC. short interest in 2021

In 2021, CHEMBIO DIAGNOSTICS, INC.'s disclosed short interest ran from 18.58% of shares outstanding on 15 Jan 2021 to 9.98% on 31 Dec 2021, a change of -8.60 percentage points. The year's high was 18.58% on 15 Jan 2021 and its low 5.84% on 15 Sep 2021, averaging 10.28% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.17 days on 28 May 2021. Full history: CHEMBIO DIAGNOSTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for CHEMBIO DIAGNOSTICS, INC. in 2021

2021 in figures

Start of year
18.58% (15 Jan 2021)
End of year
9.98% (31 Dec 2021)
Change
-8.60 pp
High
18.58% (15 Jan 2021)
Low
5.84% (15 Sep 2021)
Average
10.28%
Highest days to cover
6.17 (28 May 2021)
SEC filings marked
9

Every report in 2021

CHEMBIO DIAGNOSTICS, INC. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202118.58%3.50
29 Jan 202117.99%3.38
12 Feb 202115.68%3.85
26 Feb 202110.84%3.29
15 Mar 20219.81%2.4610-K filed, results (8-K)
31 Mar 20219.80%2.83
15 Apr 202112.07%1.00
30 Apr 202111.06%3.85
14 May 20219.94%5.0210-Q filed, results (8-K)
28 May 202111.18%6.17
15 Jun 20219.29%3.59
30 Jun 20216.90%1.97
15 Jul 20216.33%4.45
30 Jul 20217.77%1.00results (8-K)
13 Aug 20218.35%1.00results (8-K), 10-Q filed
31 Aug 202110.97%1.00
15 Sep 20215.84%1.00
30 Sep 20217.93%1.07
15 Oct 20219.12%3.25
29 Oct 20218.71%3.05
15 Nov 20218.87%2.31results (8-K), 10-Q filed
30 Nov 20219.19%1.00
15 Dec 202110.57%3.45
31 Dec 20219.98%1.70

See also: CHEMBIO DIAGNOSTICS, INC.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.